STAT3 and malignant colon neoplasm: Therefore, blocking STAT3 localization via Crm A, for example, may be an effective approach to inhibit aberrant STAT3 activity resulting in the inhibition of the phosphorylation, dimerization, or nuclear membrane transport mechanism associated with STAT3 relocation resulting in significant disruption of the cell survival signals in colon cancer.